Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
Status:
Completed
Trial end date:
2021-03-26
Target enrollment:
Participant gender:
Summary
Volunteer participants are evaluated for eligibility during a Screening Visit; those meeting
study inclusion/exclusion criteria are scheduled for 3 treatment visits. At each treatment
visit, 1 of the 3 study solutions is self-administered to both eyes. Afterwards, efficacy and
safety assessments are performed over a 3-hour period.